Patrick Bingham
Impact in
- Biological Psychiatry top 5%
- Tryptophan and brain disorders
Papers in
-
- Epigenetics and DNA Methylation 5
- RNA modifications and cancer 3
- Cancer-related gene regulation 3
- Biochemical and Molecular Research 2
- Ubiquitin and proteasome pathways 2
- Oncology 3
- Cancer Immunotherapy and Biomarkers 1
- Co-authors
- Karen A. Maegley (5 shared papers)Xiu Yu (2 shared papers)Wei Liu (2 shared papers)K.S. Gajiwala (2 shared papers)Wade C. Diehl (3 shared papers)Pei‐Pei Kung (2 shared papers)Alexei Brooun (2 shared papers)Ben Bolaños (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (2 papers)Analytical Biochemistry (1 paper)Journal of Biological Chemistry (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)ACS Medicinal Chemistry Letters (1 paper)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Patrick Bingham
14 papers receiving 448 citations
Peers
Comparison fields: 5 of 63
- Biological Psychiatry 95
- Behavioral Neuroscience 18
- Molecular Biology 323
- Psychiatry and Mental health 38
- Organic Chemistry 50
Countries citing papers authored by Patrick Bingham
This map shows the geographic impact of Patrick Bingham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Bingham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Bingham more than expected).
Fields of papers citing papers by Patrick Bingham
This network shows the impact of papers produced by Patrick Bingham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Bingham. The network helps show where Patrick Bingham may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick Bingham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 136 | |
| 2 | 2017 | 122 | |
| 3 | 2016 | 57 | |
| 4 | 2023 | 48 | |
| 5 | 2020 | 29 | |
| 6 | 2015 | 20 | |
| 7 | 2016 | 17 | |
| 8 | 2006 | 14 | |
| 9 | 2015 | 10 | |
| 10 | 2023 | 5 | |
| 11 | 2006 | 3 | |
| 12 | 2014 | 3 | |
| 13 | 2025 | 2 | |
| 14 | First-in-class KAT6A/KAT6B inhibitor CTx-648 (PF-9363) demonstrates potent anti-tumor activity in ER plus breast cancer with KAT6A dysregulation. | 2021 | 1 |
About Patrick Bingham
Patrick Bingham is a scholar working on Molecular Biology, Oncology, Cancer Research, Biological Psychiatry and Behavioral Neuroscience, having authored 14 papers that have together received 467 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (5 papers), RNA modifications and cancer (3 papers), Cancer-related gene regulation (3 papers), Biochemical and Molecular Research (2 papers), Ubiquitin and proteasome pathways (2 papers), Tryptophan and brain disorders (1 paper), Cancer Genomics and Diagnostics (1 paper) and Cancer Immunotherapy and Biomarkers (1 paper). The work is most often cited by research in Biological Psychiatry (95 citations), Behavioral Neuroscience (18 citations), Molecular Biology (323 citations), Psychiatry and Mental health (38 citations) and Organic Chemistry (50 citations). Patrick Bingham has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Karen A. Maegley, Xiu Yu, Wei Liu, K.S. Gajiwala, Wade C. Diehl, Pei‐Pei Kung, Alexei Brooun, Ben Bolaños, You-Ai He and Scott C. Sutton. Their work appears in journals such as Journal of Medicinal Chemistry, Analytical Biochemistry, Journal of Biological Chemistry, Bioorganic & Medicinal Chemistry Letters and ACS Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.